How to Use GHK-Cu: Dosage, Protocol & What to Expect

How to use GHK-Cu involves a structured injection protocol: start at 1 mg/day subcutaneously for 15 days, increase to 2 mg/day for 15 more, then rest 30 days before repeating. Compounded GHK-Cu is available at TelosRX subject to medical approval by a licensed provider, and is not FDA-approved.

GHK-Cu (copper peptide glycyl-L-histidyl-L-lysine) is one of the most studied peptides in tissue regeneration and skin biology — but most of what you’ll find online covers the science, not the protocol. This guide covers the protocol: what you need, how to reconstitute it, how to inject it, and what to expect at each phase.

Step 1: Confirm GHK-Cu Fits Your Goals

GHK-Cu is primarily studied for skin texture improvement, collagen support, hair follicle health, and wound healing. It activates sirtuin pathways and influences over 4,000 human genes associated with tissue remodeling, according to research published in Biomolecules. It is not a hormone, not a growth hormone secretagogue, and not primarily used for weight loss or sleep.

It’s a reasonable choice if your goals include skin quality, post-procedure recovery, or hair health. It stacks well with other peptides — particularly those targeting energy metabolism or immune function — because it occupies a distinct mechanistic category. Our existing overview of GHK-Cu’s mechanism and research background covers the science in depth.

All compounded GHK-Cu protocols at TelosRX are subject to medical approval by a licensed provider through asynchronous clinical review. If you’re comparing peptides for tissue repair, our guide on peptides for tendon repair covers BPC-157 and TB-500 as comparators.

Step 2: Understand the Dosing Framework Before You Start

GHK-Cu is typically used in cycles, not continuously. The standard injectable protocol uses a two-phase cycle over 30 days followed by a 30-day rest period. Continuous use without a rest period blunts receptor sensitivity and reduces efficacy in subsequent cycles.

Phase	Days	Dose	Units (Insulin Syringe)	Injection Timing
Phase 1 (Loading)	1–15	1 mg/day	4 units	Before bed, 2+ hours after last meal
Phase 2 (Escalation)	16–30	2 mg/day	8 units	Before bed, 2+ hours after last meal
Rest Period	31–60	None	—	Allow receptor sensitivity to reset

The dose escalation in Phase 2 is intentional. GHK-Cu works through cumulative tissue signaling, not peak concentration. The lower starting dose establishes tissue exposure; the higher dose in the second half reinforces collagen synthesis pathways and anti-inflammatory signaling initiated in Phase 1.

Step 3: Reconstitute Your GHK-Cu Vial

Compounded GHK-Cu arrives as a lyophilized (freeze-dried) powder and must be reconstituted before use. This is a clinical step — do it carefully and only with bacteriostatic water (NOT sterile water, which allows only single use).

1. Gather your materials: GHK-Cu vial, bacteriostatic water vial, a 3 mL syringe with needle, insulin syringes, alcohol swabs.
2. Wipe both vial tops with an alcohol swab and let dry.
3. Draw 2 mL of bacteriostatic water into the 3 mL syringe.
4. Inject the water slowly into the GHK-Cu vial — aim it at the inner glass wall, not directly onto the powder. Directing water at the glass wall avoids foam formation and peptide degradation.
5. Roll gently between your palms until the powder is fully dissolved. Do not shake.
6. Refrigerate immediately in a closed box (not freezer). Reconstituted peptide is stable for 30 days refrigerated at proper temperature.

At 2 mL of diluent with a standard 5 mg vial, the resulting concentration is 2.5 mg/mL. One vial at this concentration provides enough for a full 30-day cycle at both dose levels. Confirm your vial’s dose with your provider, as compounded formulations vary.

Step 4: Prepare Your Injection Site

GHK-Cu is injected subcutaneously (SQ) — into the fatty tissue just under the skin, not into muscle. The preferred site is the abdomen, in the soft tissue lateral to the navel (roughly 1–2 inches to either side).

• Wash your hands thoroughly before handling any supplies.
• Wipe the injection site with an alcohol swab and allow it to fully dry before inserting the needle. Wet alcohol on skin increases sting.
• Rotate sites with each injection. Injecting the same spot repeatedly causes lipohypertrophy — a thickened, lumpy area that reduces absorption.
• Let the GHK-Cu vial reach room temperature for a few minutes before drawing. Cold peptide solution can sting.

Step 5: Inject Correctly

Use an insulin syringe for each dose. Draw 4 units for Phase 1, 8 units for Phase 2.

1. Draw the correct dose from your reconstituted vial using the insulin syringe.
2. Pinch a fold of skin at your prepared injection site.
3. Insert the needle at a 45-degree angle into the pinched tissue.
4. Slowly depress the plunger — push steadily over about 5 seconds.
5. Withdraw the needle and apply gentle pressure with a clean swab. Do not rub.
6. Dispose of the used syringe immediately in a sharps container. Never reuse needles.

If you experience redness or mild swelling at the injection site, it’s the most common reaction to GHK-Cu and typically resolves within a few hours. Persistent redness, warmth, or pain may indicate an infection and warrants contact with your provider. Because TelosRX is asynchronous, you can message your clinical team any time without scheduling an appointment.

Step 6: Track Results by Cycle

GHK-Cu results are cumulative and cycle-dependent. A study on GHK-Cu’s effects on dermal cell activity confirms the peptide’s role in activating follicle cycling and collagen remodeling — but these processes take time to manifest visibly.

• End of Cycle 1 (days 1–30): Most people notice subtle skin texture changes. Some report improved hair quality toward the end. Results at this stage are often “something feels different” rather than “I can see a clear change.”
• Rest period (days 31–60): Continue monitoring. Some of the collagen reorganization happens in this window. Do not restart the cycle early.
• End of Cycle 2: More visible improvements in skin tone, texture, and hair quality. This is typically when before/after photos become meaningful.

For peptides with different applications — like CJC-1295 and Ipamorelin for growth hormone support — see our guide on growth hormone peptide stacks. GHK-Cu can run alongside these protocols; it occupies a different mechanistic space.

Step 7: Observe the 30-Day Rest Period

After day 30, stop injections for a full 30 days. This isn’t optional. GHK-Cu’s mechanism depends on receptor signaling, not accumulation. Continuous dosing without a break progressively blunts the signaling pathways the peptide activates — meaning each subsequent cycle becomes less effective.

The rest period is also a good time to evaluate. Are the results aligned with your goals? Is GHK-Cu the right standalone approach, or does your situation call for additional peptides targeting different pathways? These are questions worth discussing with your TelosRX clinical team before starting Cycle 2.

GHK-Cu Safety: Who Should Not Use This Peptide

GHK-Cu has a strong safety profile at clinical doses, with minor injection site redness as the most commonly reported reaction. However, it is generally not recommended for:

• Individuals with active malignancies. GHK-Cu promotes tissue growth signals that could theoretically support cancer cell proliferation.
• People with a history of hormone-sensitive cancers — consult with your oncologist before starting.
• Pregnancy or breastfeeding. Insufficient safety data exists for these populations.

As with all compounded peptides at TelosRX, a provider review assesses your medical history before any prescription is issued. Approval is not guaranteed.

Frequently Asked Questions

How long before I see results from GHK-Cu?

Most people notice initial skin texture changes toward the end of the first 30-day cycle. Hair quality improvements are more commonly observed after the second cycle, following the 30-day rest. GHK-Cu is not a fast-acting compound — its effects are cumulative and become clearer over two to three cycles.

Can GHK-Cu be used topically instead of injected?

Topical GHK-Cu (typically as a serum or cream) is widely available and studied for skin benefits. Injected GHK-Cu produces systemic effects that topical application cannot replicate — particularly for hair follicle health and wound healing. The protocols differ significantly. Compounded injectable GHK-Cu at TelosRX requires a provider-issued prescription and is not FDA-approved.

What concentration of bacteriostatic water do I use to reconstitute GHK-Cu?

Standard practice is 2 mL of bacteriostatic water per vial. The resulting concentration depends on your vial’s total dose. With a 5 mg vial and 2 mL of diluent, you get 2.5 mg/mL. Always confirm with your provider or the compounding pharmacy’s reconstitution label — do not adjust the ratio without guidance.

Is GHK-Cu safe to stack with other peptides?

Generally yes. GHK-Cu targets tissue remodeling and collagen pathways, which doesn’t overlap mechanistically with peptides targeting growth hormone release, cognition, or immune function. Never mix different peptides in the same syringe or vial. Inject each from its own vial using its own syringe.

What if I miss a day?

Skip the missed day and continue from where you left off. Do not double-dose. The 30-day cycle tolerates occasional missed days without significantly affecting outcomes. Missing multiple consecutive days warrants a conversation with your provider about whether to restart the cycle.

Does GHK-Cu require refrigeration?

Before reconstitution: lyophilized peptide can typically be stored at room temperature away from light and heat. After reconstitution: yes, refrigerate immediately and keep in a closed container. Never freeze reconstituted peptide — freezing degrades the solution. Reconstituted GHK-Cu is typically stable for up to 30 days refrigerated.

TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.

Start your private evaluation at TelosRX.